Alzocin-D is a combination formulation of Alfuzosin Hydrochloride IP 10 mg and Dutasteride 0.5 mg designed to support the management of benign prostatic hyperplasia (BPH) and improve urinary flow under medical supervision.
Colshine-0.5 is a Colchicine IP 0.5 mg formulation designed to support the management of gout and inflammatory conditions associated with uric acid crystal deposition under medical supervision.
Darifen-15 is a Darifenacin Hydrobromide IP 15 mg formulation designed to support the management of overactive bladder symptoms and improve urinary control under medical supervision.
Fabilent-80 is a Febuxostat 80 mg formulation designed to support the management of hyperuricemia and gout by helping maintain healthy uric acid levels under medical supervision.
Silofirst-8D is a combination formulation of Silodosin 8 mg and Dutasteride IP 0.5 mg designed to support the management of benign prostatic hyperplasia (BPH) and improve urinary flow under medical supervision.
Temsujohn-0.4 is a Tamsulosin Hydrochloride IP 0.4 mg formulation designed to support the management of benign prostatic hyperplasia (BPH) and improve urinary flow under medical supervision.
Urinac-50 is a Bethanechol Chloride USP 50 mg formulation designed to support bladder function and assist in the management of urinary retention under medical supervision.
